Nasdaq
$10.40▼ 0.38%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $345.8MShares out 33.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 10.16After-hours26.10.17 05:318-K/AKey event#●●●
Mobia Medical, Inc.
Mobia Medical, Inc. appointed Dr. Myriam J. Curet to its nominating and corporate governance committee, effective October 15, 2026. This filing serves as an amendment to the previously reported Form 8-K to include this committee appointment.…more
$10.40-0.38%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16After-hours26.10.17 05:308-K/AKey event
Mobia Medical, Inc.
Mobia Medical, Inc. appointed Dr. Reza Zadno to its audit committee, effective October 15, 2026. Dr. Zadno will continue to serve on the company's compensation committee while assuming his new responsibilities on the audit committee.…more
$10.40-0.38%vs prev closeView filingShare - 9.15After-hours26.09.16 05:344Ownership
Mobia Medical, Inc.
Insider Leavitt Chase C. of Mobia Medical, Inc. filed a Form 4 statement regarding changes in beneficial ownership of securities on September 11, 2026. This filing formalizes the reported changes in the insider's equity holdings.…more
$10.40-0.38%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.15After-hours26.10.16 05:05#●●●#●●●
Mobia Medical to Report Q3 2026 Financial Results on Nov 5
Mobia Medical announced that it will release its financial results for the third quarter of 2026 on November 5, 2026. The company will host a conference call and webcast to discuss the results and provide a corporate update.…more
$10.40-0.38%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.28Pre-market26.08.28 20:32
●●●●●●●● ●●●●● ●●●●●●
Mobia Medical's paired vagus nerve stimulation technology has been included in the 2026 AHA/ASA adult stroke rehabilitation guidelines as an option for improving upper-limb function. This inclusion marks a significant recognition of the clinical efficacy of their treatment approach.…more
$10.40-0.38%vs prev closeShareBenzinga - 8.28Pre-market26.08.28 20:30
●●●●●●●● ●●●●● ●●●●●●
Mobia Medical's paired Vagus Nerve Stimulation (VNS) therapy has been recognized in the 2026 American Heart Association stroke rehabilitation guidelines. While this validates the clinical approach, the direct impact on future revenue remains to be seen.…more
$10.40-0.38%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report